Profiel
John Hayslip currently works at Verastem, Inc., as Chief Medical Officer from 2024.
Dr. Hayslip also formerly worked at The Markey Cancer Center Foundation, as Director-Clinical Research & Data Management, Nektar Therapeutics, as Vice President-Clinical Development, and I-Mab, as Chief Medical Officer from 2022 to 2024.
Dr. Hayslip received his graduate degree from The Medical University of South Carolina and doctorate degree from Northeast Ohio Medical University.
Actieve functies van John Hayslip
| Bedrijven | Functie | Begin |
|---|---|---|
| VERASTEM, INC. | Hoofd Techniek/Wetenschap/O&O | 18-04-2024 |
Eerdere bekende functies van John Hayslip
| Bedrijven | Functie | Einde |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Hoofd Techniek/Wetenschap/O&O | 15-04-2024 |
The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van John Hayslip
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Medical University of South Carolina
Medical University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Markey Cancer Center Foundation | |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Northeast Ohio Medical University
Northeast Ohio Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
















